Only about two months after the Biden administration pushed out the COVID boosters, a new study finds that the injections are not as effective as the admin is claiming.
Per Just the News:
New preprint studies by researchers at Columbia University and Beth Israel Deaconness Medical Center, not yet peer-reviewed, found that the bivalents showed no meaningful improvement over the original monovalent boosters that targeted the Wuhan strain alone.
CDC Director Rochelle Walensky got infected by COVID this past weekend, just a month after taking her bivalent booster. The new boosters are “formulated to better protect against” newer variants, she said when recommending them in September.
“Ironically, this is probably the peak vaccine efficacy (peak Ab),” University of California San Francisco epidemiologist Vinay Prasad wrote in his newsletter Wednesday, referring to Walensky’s ill-timed breakthrough.
“Their entire vaccine policy seems to be interested in giving Pfizer and Moderna a perpetual market share for a yearly vaccine,” he said. “But seems to have no interest in generating credible randomized control trial evidence to inform the public.”
The claims that these boosters are “better” or “improved” is simply not telling the truth, the report said.
Human data on Pfizer's bivalent booster!
At 1 wk, Wuhan booster in 40 ppl>55 "elicited more limited increases" in nAb vs bivalent. Interesting phrasing🧐
Assume results not dramatic.
Saw this at 1 mo w/ BA1/Wuhan bivalent, & its VE was no better. pic.twitter.com/VQ0b5CFRek
— Buzz Hollander MD (@buzzhollandermd) October 13, 2022
Just the News has a lot more information on this topic, so go on over to the post and review the data.Commentary